Showing 2,301 - 2,320 results of 3,138 for search '"Intestine"', query time: 0.06s Refine Results
  1. 2301
  2. 2302

    The macroanatomic investigations on the formation of the cisterna chyli and thoracic duct in akkaraman sheep by Hakan Yalçın, Sadettin Tıpırdamaz, Kamil Beşoluk

    “…Visceral trunks is formed by the jejenal, intestinal and colic trunks. The celiac trunks is formed by the hepatic and gastric trunks.…”
    Get full text
    Article
  3. 2303

    Characteristics, pathogenic and therapeutic role of gut microbiota in immunoglobulin A nephropathy by Kaijin Yao, Lingqian Zheng, Wenmin Chen, Yina Xie, Chunling Liao, Tianbiao Zhou

    Published 2025-02-01
    “…Gut microbiota may be involved in the development and progression of IgAN through three main aspects: destruction of intestinal barrier, changes in metabolites and abnormal mucosal immunity. …”
    Get full text
    Article
  4. 2304

    Colonic Polyps in Children and Adolescents by Carol A Durno

    Published 2007-01-01
    “…Adolescents and adults with multiple juvenile polyps are at a significant risk of intestinal cancer. The challenge for adult and pediatric gastroenterologists is determining the precise risk of colorectal cancer in patients with juvenile polyposis syndrome. …”
    Get full text
    Article
  5. 2305

    Closed-loop obstruction due to internal hernia: An atypical clinical presentation of acute abdomen — A case report by Varsha Chinta, Sunil M Krishna, Vivek Ramesh Udupi

    Published 2024-12-01
    “…After baseline blood investigations and imaging, a diagnosis of subacute intestinal obstruction was made. As she clinically worsened over 24 h, CT imaging was done, which suggested acute small bowel obstruction secondary to adhesions. …”
    Get full text
    Article
  6. 2306

    Inflammatory Bowel Disease and Statins by V. V. Genkel, I. I. Shaposhnik

    Published 2020-04-01
    “…Simvastatin changed the composition of the intestinal microflora, which had a potential anti-inflammatory effect. …”
    Get full text
    Article
  7. 2307

    Wu-Mei-Wan enhances brown adipose tissue function and white adipose browning in obese mice via upregulation of HSF1 by Shen Chen, Kexin Nie, Hongzhan Wang, Yang Gao, Xinyue Jiang, Hao Su, Zhi Wang, Yueheng Tang, Fuer Lu, Hui Dong, Jingbin Li

    Published 2025-01-01
    “…Short-chain fatty acids (SCFAs) in the intestines were measured to determine if WMW’s effects on HSF1 are mediated through SCFAs. …”
    Get full text
    Article
  8. 2308

    Correlation analysis of the impact of Clonorchis sinensis juvenile on gut microbiota and transcriptome in mice by Xueling Deng, Shitao Li, Yuhong Wu, Jiali Yao, Wei Hou, Jiangyao Zheng, Boying Liang, Xiaole Liang, Qiping Hu, Zhanshuai Wu, Zeli Tang

    Published 2025-02-01
    “…It induced liver inflammation, promoted intestinal villi growth, and altered goblet cell numbers. …”
    Get full text
    Article
  9. 2309
  10. 2310
  11. 2311

    Hypothermia during Surgical Treatment of Type A Aortic Dissection: A 16 Years’ Experience by Francesco Macrina, Maria Cristina Acconcia, Luigi Tritapepe, Mizar D’abramo, Wael Saade, Alessandra Capelli, Fabio Miraldi

    Published 2020-01-01
    “…The global incidence of complications was statistically reduced in HT group: we found a statistical significant reduction of intestinal ischemia, and a similar trend also for other complications analyzed, such as infections. …”
    Get full text
    Article
  12. 2312

    The gut–kidney axis is regulated by astragaloside IV to inhibit cyclosporine A-induced nephrotoxicity by Cong Han, Ran-ran Gao, Le Zhou, Wei Li

    Published 2025-01-01
    “…The target genes and metabolites of AS-IV were further validated. AS-IV inhibited intestinal-derived urinary toxins and improved renal tissue apoptosis, lipid accumulation, collagen deposition, and mitochondrial damage.ConclusionAS-IV improved CICN through the coexpression of the gut–transcriptome–metabolome network. …”
    Get full text
    Article
  13. 2313

    Three-way relationships between gut microbiota, helminth assemblages and bacterial infections in wild rodent populations by Bouilloud, Marie, Galan, Maxime, Dubois, Adelaide, Diagne, Christophe, Marianneau, Philippe, Roche, Benjamin, Charbonnel, Nathalie

    Published 2023-02-01
    “…We applied analyses of community and microbial ecology to evaluate the interactions between the gut bacteriota, the gastro-intestinal helminths and the pathogenic bacteria detected in the spleen. …”
    Get full text
    Article
  14. 2314

    The Croton genera (Euphorbiaceae) and its richness in chemical constituents with potential range of applications by Carlos Andrés Coy-Barrera, Laura Galvis, Maria Juliana Rueda, Sergio Alejandro Torres-Cortés

    Published 2025-02-01
    “…Ethnobotanical studies reflect numerous uses in different communities, addressing issues such as intestinal disorders, general pain, cancer, hypertension, diabetes, hemorrhoids, sexual impotence, respiratory diseases, COVID -19, ulcers, and intestinal parasites. …”
    Get full text
    Article
  15. 2315

    Pancreatic pseudocyst and complicated internal hernia. A case report by Miguel Licea Videaux, Iván Ulises Palacios Morejón, Orlando Zamora Santana, Josué Vázquez Arizmendi, Richard Juan Chacón Melcón

    Published 2023-03-01
    “…The acute abdominal picture secondary to the complication of these is related to intestinal occlusion and necrosis. Sometimes, some diseases that precede or are discovered during the clinical condition, such as pancreatic pseudocyst, can make a positive diagnosis difficult. …”
    Get full text
    Article
  16. 2316

    Contribution of Gut Bacteria to Liver Pathobiology by Gakuhei Son, Michael Kremer, Ian N. Hines

    Published 2010-01-01
    “…Receiving approximately 70% of its blood supply from the intestinal venous outflow, the liver represents the first line of defense against gut-derived antigens and is equipped with a broad array of immune cells (i.e., macrophages, lymphocytes, natural killer cells, and dendritic cells) to accomplish this function. …”
    Get full text
    Article
  17. 2317

    Lactobacillus rhamnosus: An emerging probiotic with therapeutic potential for depression by Jing Feng, Qiuyu Cen, Yanru Cui, Xiaomin Hu, Min Li, Linjie Wang, Juanfang Wei, Nianyi Sun, Junyu Wang, Anren Zhang

    Published 2025-01-01
    “…This review preliminarily explores the clinical significance of Lactobacillus rhamnosus in the treatment of depression and summarizes the potential mechanisms by which Lactobacillus rhamnosus treats depression, including its regulation of gut microbiota, alterations in gene expression, improvement of intestinal barrier function, maintenance of neurotransmitter balance, suppression of inflammatory responses, modulation of the immune system, coping with oxidative stress, and optimization of metabolic processes. …”
    Get full text
    Article
  18. 2318

    Whipple's Disease in a 61-Year-Old Patient. Clinical Follow-Up by Zh. G. Simonova, О. V. Pestereva, D. A. Dyakonov, М. А. Karepanov, М. S. Ralnikova

    Published 2024-05-01
    “…Therapy with ceftriaxone for 14 days, therapy with trimethoprim-sulfamethoxazole (160 mg/800 mg twice a day) for 14 months resulted in positive clinical dynamics, improvement of laboratory parameters, disappearance of PAS-positive macrophages in the small intestinal mucosa, indicating remission of the disease.…”
    Get full text
    Article
  19. 2319

    Preventive role of Pastinaca sativa in mitigating metabolic dysfunction-associated steatotic liver disease via modulation of metabolic endotoxemia by Ji-Eun Park, Hye-Bin Lee, Yu Ra Lee, Guijae Yoo, Hee-Kyoung Son, Sang Yoon Choi, Miri Park, Ho-Young Park

    Published 2025-02-01
    “…Additionally, PRE enhanced gut health by reducing endotoxins, improving intestinal permeability, and upregulating tight junction proteins. …”
    Get full text
    Article
  20. 2320

    Engineering Saccharomyces cerevisiae for medical applications by Carla Maneira, Alexandre Chamas, Gerald Lackner

    Published 2025-01-01
    “…Main text In this review, we scrutinize the main applications of engineered S. cerevisiae in the medical field focusing on its use as a cell factory for pharmaceuticals and vaccines, a biosensor for diagnostic and biomimetic assays, and as a live biotherapeutic product for the smart in situ treatment of intestinal ailments. An extensive view of these fields' academic and commercial developments as well as main hindrances is presented. …”
    Get full text
    Article